How Health System Leaders Are Responding to Medicare Advantage Pressures

Why It Matters

The shift threatens health‑system margins and could reshape provider‑payer relationships across the industry, prompting strategic realignment of Medicare Advantage strategies.

Key Takeaways

• Declining MA reimbursement pressures health system margins
• 60% expect lower payments; 74% anticipate more denials
• Systems invest in revenue-cycle automation to cut denials
• Some systems exit or double down on own MA plans
• Strategic payer portfolio management becoming priority

Pulse Analysis

Medicare Advantage, once a growth engine for hospitals, is now a liability for many health systems. Recent CMS rate cuts, tighter utilization reviews, and a surge in claim denials have compressed the traditional 100 % fee‑schedule benchmark that providers rely on in Traditional Medicare. The Alvarez & Marsal survey captures this reality: 60 % of executives anticipate lower reimbursements, and more than two‑thirds expect heightened operational friction. These pressures are especially acute in rural markets where insurers are pulling back product offerings, leaving providers with fewer network options and greater financial uncertainty.

To counteract the margin squeeze, health systems are turning to technology and process redesign. Over 70 % are allocating capital to revenue‑cycle tools that improve coding accuracy and automate claim submission, while 60 % focus on denial‑reduction platforms. Such investments not only accelerate first‑pass payment rates but also generate data insights that inform negotiations with payers. In parallel, organizations are re‑evaluating their participation in value‑based contracts, shedding high‑risk arrangements and deepening ties with insurers that offer transparent quality‑based incentives.

The strategic response extends beyond operational tweaks to a broader portfolio mindset. Leaders are mapping each payer relationship against financial return and patient experience, pruning contracts that erode balance sheets and expanding those that align incentives. Some systems are exiting their own Medicare Advantage subsidiaries, while others with sufficient scale are doubling down to gain bargaining power. This disciplined, three‑phase approach—diagnostic assessment, targeted execution, and continuous monitoring—positions health systems to navigate the evolving MA landscape, protect cash flow, and sustain competitive advantage.